Recent Patents on Anti-Cancer Drug Discovery This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma
CONCLUSION: CK2B is a biomarker for HCC prognosis and could be a potential new drug target. Moreover, the association between infiltrating immune cells and CK2B in the HCC tumor microenvironment might provide a solid basis for further investigation and a potent strategy for immunotherapy of HCC.PMID:37779404 | DOI:10.2174/0115748928262221230925090120 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - October 2, 2023 Category: Cancer & Oncology Authors: Huiru Dai Minling Liu Yuxi Pan Tingwei Li Yihang Pan Zhesheng Chen Jing Li Yuchen Liu Shuo Fang Source Type: research

Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model
CONCLUSION: The findings imply that gefitinib has negative effects on the skin and colon. Gefitinib- induced skin and colon adverse reactions in mice have been successfully modeled in this study.PMID:37723963 | DOI:10.2174/1574892818666230727143750 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Yalei Wang Shuo Cheng Huawei Zhang Yali Zhang Chengcheng Ding Tiantian Peng Weihang Chen Ke Yang Jiani Zhang Yan Tan Xu Wang Zhaoheng Liu Peng Wei Miao Jiang Qian Hua Source Type: research

Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer
CONCLUSION: In this study, we demonstrated a lipid metabolism-related genes prognosis biomarker associated with the tumor immune micro-environment in patients with CRC.PMID:37723964 | DOI:10.2174/1574892818666230731121815 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Jing Zhan Wei Cen Junchang Zhu Yunliang Ye Source Type: research

Research progress on the anticancer activity of plant polysaccharides
Recent Pat Anticancer Drug Discov. 2023 Sep 15. doi: 10.2174/1574892819666230915103434. Online ahead of print.ABSTRACTTumor is a serious threat to human health, with extremely high morbidity and mortality rates. However, tumor treatment is challenging, and the development of antitumor drugs has always been a significant research focus. Plant polysaccharides are known to possess various biological activities. They have many pharmacological properties such as immunomodulation, antitumor, antiviral, antioxidative, antithrombotic, and antiradiation effects, reduction of blood pressure and blood sugar levels, and protection fro...
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Qiaoyan Liu Bo Song Sen Tong Qiuqiong Yang Huanhuan Zhao Jia Guo Xuexia Tian Renjie Chang Junzi Wu Source Type: research

Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model
CONCLUSION: The findings imply that gefitinib has negative effects on the skin and colon. Gefitinib- induced skin and colon adverse reactions in mice have been successfully modeled in this study.PMID:37723963 | DOI:10.2174/1574892818666230727143750 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Yalei Wang Shuo Cheng Huawei Zhang Yali Zhang Chengcheng Ding Tiantian Peng Weihang Chen Ke Yang Jiani Zhang Yan Tan Xu Wang Zhaoheng Liu Peng Wei Miao Jiang Qian Hua Source Type: research

Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer
CONCLUSION: In this study, we demonstrated a lipid metabolism-related genes prognosis biomarker associated with the tumor immune micro-environment in patients with CRC.PMID:37723964 | DOI:10.2174/1574892818666230731121815 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Jing Zhan Wei Cen Junchang Zhu Yunliang Ye Source Type: research

Research progress on the anticancer activity of plant polysaccharides
Recent Pat Anticancer Drug Discov. 2023 Sep 15. doi: 10.2174/1574892819666230915103434. Online ahead of print.ABSTRACTTumor is a serious threat to human health, with extremely high morbidity and mortality rates. However, tumor treatment is challenging, and the development of antitumor drugs has always been a significant research focus. Plant polysaccharides are known to possess various biological activities. They have many pharmacological properties such as immunomodulation, antitumor, antiviral, antioxidative, antithrombotic, and antiradiation effects, reduction of blood pressure and blood sugar levels, and protection fro...
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Qiaoyan Liu Bo Song Sen Tong Qiuqiong Yang Huanhuan Zhao Jia Guo Xuexia Tian Renjie Chang Junzi Wu Source Type: research

Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model
CONCLUSION: The findings imply that gefitinib has negative effects on the skin and colon. Gefitinib- induced skin and colon adverse reactions in mice have been successfully modeled in this study.PMID:37723963 | DOI:10.2174/1574892818666230727143750 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Yalei Wang Shuo Cheng Huawei Zhang Yali Zhang Chengcheng Ding Tiantian Peng Weihang Chen Ke Yang Jiani Zhang Yan Tan Xu Wang Zhaoheng Liu Peng Wei Miao Jiang Qian Hua Source Type: research

Development of a Novel Lipid Metabolism-related Gene Prognostic Signature for Patients with Colorectal Cancer
CONCLUSION: In this study, we demonstrated a lipid metabolism-related genes prognosis biomarker associated with the tumor immune micro-environment in patients with CRC.PMID:37723964 | DOI:10.2174/1574892818666230731121815 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Jing Zhan Wei Cen Junchang Zhu Yunliang Ye Source Type: research

Research progress on the anticancer activity of plant polysaccharides
Recent Pat Anticancer Drug Discov. 2023 Sep 15. doi: 10.2174/1574892819666230915103434. Online ahead of print.ABSTRACTTumor is a serious threat to human health, with extremely high morbidity and mortality rates. However, tumor treatment is challenging, and the development of antitumor drugs has always been a significant research focus. Plant polysaccharides are known to possess various biological activities. They have many pharmacological properties such as immunomodulation, antitumor, antiviral, antioxidative, antithrombotic, and antiradiation effects, reduction of blood pressure and blood sugar levels, and protection fro...
Source: Recent Patents on Anti-Cancer Drug Discovery - September 19, 2023 Category: Cancer & Oncology Authors: Qiaoyan Liu Bo Song Sen Tong Qiuqiong Yang Huanhuan Zhao Jia Guo Xuexia Tian Renjie Chang Junzi Wu Source Type: research